Dexcom CGM HypoDE Study Summary - AMSL Diabetes

Dexcom CGM HypoDE Study Summary

This study examines the impact of the Dexcom G5® Mobile CGM System use in patients on multiple daily injections (MDI) insulin therapy with a history of SH or IHA.

Stay informed with AMSL Diabetes

Now you can get all the latest news and updates of our products, events and resources right into your inbox.

Something went wrong. Please try again later!

Send AMSL Diabetes a message

We are always happy to help, send us a message or enquiry

Back to top